Dan Cao - Publications, H-index & Citations

Dan Cao

nutrition and food safety

36H指数

237论文数

4.9K被引数

收录论文 91

发表时间

Nutrition and health canteen-based lifestyle intervention: association with weight management; lipid metabolism regulation; and inflammation alleviation in middle-aged adults 营养与健康管理食堂为基础的生活方式干预：与体重管理；脂质代谢调节；以及炎症缓解在中年成人中的关联

Frontiers in Nutrition

IF5.1

2026-04-01

OAAI

XL Xiaoqin Luo; XG Xiaoxiao Guo; HC Haige Cao; DC Dan Cao; GL Guohua Li; XW Xinyue Wang; JL Jun Liu; YD Yimei Du; YY Yuexin Yang

Development and validation of an interpretable machine learning–based model for predicting carbapenem-resistant Acinetobacter baumannii infection in postoperative ICU patients: a retrospective cohort study 基于可解释机器学习模型预测术后ICU患者碳青霉烯耐药鲍曼不动杆菌感染的建立与验证：一项回顾性队列研究

Frontiers in Cellular and Infection Microbiology

IF4.8

2026-03-30

OAAI

YG Yan Gao †; GG Guangxin Gu †; RW Ruiwen Wang †; CJ Chen Jia; FZ Feng Zhao; DC Dan Cao; XJ Xin Jin; XM Xiaoyuan Ma; YW Yu Wang; XL Xueyu Li

The Nano-system Combines Mitochondrial Damage with Microtubule Stabilization for Cancer Metastasis Suppression 该纳米系统结合线粒体损伤与微管稳定化以抑制癌症转移

J. Mater. Chem. B

IF0

2025-10-16

PREAI

Zhanghan Wu; Jing Tao; Yuan Yao; Yuan Huang; Lian Li; Dan Cao; Zhou Zhou

Retraction Note: Spironolactone inhibits apoptosis in rat mesangial cells under hyperglycaemic conditions via the Wnt signalling pathway 撤稿说明：Spironolactone在高糖条件下通过Wnt信号通路抑制大鼠系膜细胞的凋亡

Molecular and Cellular Biochemistry

IF3.7

2025-09-06

PREAI

Dan Zhu; Hongwei Yu; Hongjiang He; Jiuli Ding; Jie Tang; Dan Cao; Lirong Hao

LGR5/mTORC2 axis regulates cellular metabolic plasticity to maintain tumorigenesis in hepatocellular carcinoma LGR5/mTORC2轴调控细胞代谢可塑性以维持肝细胞癌的肿瘤发生。

Cancer Letters

IF10.1

2025-08-10

PREAI

Guishuai Lv; Qianni Zong; Liang Wang; Hongwei Lv; Zixin Wu; Chunying Liu; Suyang Wang; Dan Cao; Hongyang Wang; Wen Yang

Augmenter of liver regeneration (ALR) can regulate iron homeostasis through the INOS/NO/SLC39A14 pathway to reduce ferroptosis in acute kidney injury 肝再生增强因子（ALR）可通过INOS/NO/SLC39A14通路调节铁稳态，以减少急性肾损伤中的铁死亡。

FEBS JOURNAL

IF4.2

2025-04-25

PREAI

Fangyan Tan; Dan Cao; Lili Huang; Yixin Ma; Chunxia Wang; Zheng Zhang; Xiaohui Liao

Efficacy and safety of immune checkpoint inhibitors in advanced biliary tract cancer: a real-world study 免疫检查点抑制剂在晚期胆道癌中的疗效与安全性：一项真实世界研究

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-03-31

OAAI

Zheng, Yichen; Guo, Jiamin; Ren, Tonghui; Ma, Ji; Cao, Dan

Will the increase of medical equipment affect medical expenditure? Empirical evidence from a quasi-experiment in China 医疗设备的增加会影响医疗支出吗？来自中国一项准实验的实证证据

health services research

IF3

2025-01-15

OAAI

Deng, Qiwei; Zhou, Zhongliang; Shen, Chi; Cao, Dan; Zhao, Dantong; Zhao, Yaxin; Gao, Jianmin

Myelofibrosis predicts deep molecular response 4.5 in chronic myeloid leukaemia patients initially treated with imatinib: An extensive, multicenter and retrospective study to develop a prognostic model

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2024-11-22

OAAI

Zeng, Tian; Yang, Xiudi; Wang, Yi; Wu, Dijiong; Feng, Weiying; Lu, Ying; Zhu, Xiaoqiong; Liu, Lirong; Zhou, Mei; Zhang, Li; Shao, Yanping; Qian, Honglan; Zhu, Feng; Chen, Yu; Cao, Dan; Huang, Li; Feng, Xiaoning; Chen, Lili; Zhang, Gang; Le, Jing; Zhu, Weiguo; Xia, Yongming; Han, Yanxia; Jia, Yongqing; Tian, Guoyan; Zhou, Hui; Xu, Linjuan; Yin, Xiufeng; Tang, Qinli; Zhang, Yuefeng; Yao, Guoli; Lang, Xianghua; Zhang, Kaifeng; Zhou, Xiujie; Guo, Junbin; Tu, Jinming; Zhao, Jianzhi; Wu, Gongqiang; Zhang, Huiqi; Wu, Xiao; Luo, Qiulian; Cao, Lihong; Chu, Binbin; Jiang, Wei; Wu, Haiying; Huang, Liansheng; Hu, Meiwei; He, Muqing; Zhu, Jingjing; Tong, Hongyan; Jin, Jie; Huang, Jian

Risk factors for regional lymph node metastasis in rectal neuroendocrine tumors: a population-based study

FRONTIERS IN MEDICINE

IF3

2024-09-04

OAAI

Li, Ruizhen; Li, Xiaofen; Wang, Yan; Chang, Chen; Lv, Wanrui; Li, Xiaoying; Cao, Dan

Preliminary phase I results from a first-in-human study of ZG006, a trispecific anti-T cell engager targeting CD3/DLL3/DLL3, as monotherapy in patients with advanced small cell lung cancer or neuroendocrine carcinoma ZG006（一种靶向CD3/DLL3/DLL3的三特异性抗T细胞结合剂）首次人体研究的初步I期结果，该研究作为单药治疗用于晚期小细胞肺癌或神经内分泌癌患者。

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Wang, Q.; Chai, X.; Lin, R.; Zheng, L.; Cao, D.; Qu, X.; Liu, L.; Wu, L.; Mou, H.; Xu, Q.; Shi, J.

Heterogeneous Uptake of 68Ga-DOTATATE and 18F-FDG in Initial Diagnosed Neuroendocrine Tumors Patients

CLINICAL NUCLEAR MEDICINE

IF9.6

2024-04-19

PREAI

Zhou, Yi; Li, Li; Wang, Hui; Huang, He-xiao; Cao, Dan; Ke, Neng-wen; Su, Ming-gang; Tian, Rong

Case report: Diverse immune responses in advanced pancreatic ductal adenocarcinoma treated with immune checkpoint inhibitor-based conversion therapies

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-02-13

OAAI

Li, Xiaoying; Xiao, Chaoxin; Li, Ruizhen; Zhang, Pei; Yang, Heqi; Cao, Dan

Med23 deficiency reprograms the tumor microenvironment to promote lung tumorigenesis

BRITISH JOURNAL OF CANCER

IF6.8

2024-01-09

OAAI

Fu, Xiaobo; Liu, Siming; Cao, Dan; Li, Chonghui; Ji, Hongbin; Wang, Gang

Development and validation of a model for the early prediction of progression from essential thrombocythemia to post-essential thrombocythemia myelofibrosis: multicentre retrospective study 从原发性血小板增多症到原发性血小板增多症后骨髓纤维化早期预测模型的开发和验证: 多中心回顾性研究

ECLINICALMEDICINE

IF10

2024-01-01

OAAI

Xiang, Danhong; Yang, Xiudi; Qian, Honglan; Zhang, Li; Han, Yanxia; Sun, Yongcheng; Lu, Ying; Chen, Yu; Cao, Dan; Hu, Meiwei; Wang, Lifeng; Tang, Qinli; Wu, Dijiong; Tian, Guoyan; Tong, Hongyan; Jin, Jie; Huang, Jian

SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer

BIOMEDICINES

IF3.9

2023-10-25

OAAI

Zhang, Pei; Yang, Heqi; Zhu, Kaiguo; Chang, Chen; Lv, Wanrui; Li, Ruizhen; Li, Xiaoying; Ye, Tinghong; Cao, Dan

Regional lymph node metastasis risk factors for rectal neuroendocrine tumors: A population-based study

ANNALS OF ONCOLOGY

IF65.4

2023-10-01

OAAI

Cao, D.; Li, R.; Li, X.; Chang, C.; Lv, W.; Xiaoying, L.